Categories Earnings, LATEST, Other Industries

Bio-Path’s loss expands in Q2

Biotech company Bio-Path Holdings (NASDAQ: BPTH) reported a loss of $2.5 million or $0.87 per share for the second quarter ended June 30, 2019, compared to a loss of $1.7 million or $2.96 per share for the second quarter ended June 30, 2018. Bio-Path has not generated significant revenues to date. The company’s revenue generation in the future depends on the successful development and eventual commercialization of its drug candidates.

Research and development expenses increased to $1.5 million from $0.8 million in the prior-year quarter, primarily due to the commencement of activities related to Stage 2 of Phase 2 clinical trial in AML.

Read: Arcadia Biosciences (RKDA) swings to profit in Q2

As of June 30, 2019, the company had cash of $17.1 million, compared to $1.0 million at December 31, 2018. Net cash used in operating activities for the six months ended June 30, 2019 was $4.2 million compared to $3.4 million for the comparable period in 2018.

“Throughout the second quarter we continued to execute on our clinical development plans for our innovative RNAi nanoparticle therapeutics,” said CEO Peter Nielsen.

He added, “We are also looking forward to completing Investigational New Drug (IND) enabling studies of BP1003, a novel liposome-incorporated STAT3 oligodeoxynucleotide inhibitor for the treatment of pancreatic cancer, and to file an IND application for a Phase 1 study of BP1003 for the treatment of pancreatic cancer in 2020.”

Bio-Path stock closed down 0.91% at $11.96 yesterday and has dipped 33% in the past three months.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

After a weak first half, will NIKE (NKE) hit the recovery path this year?

After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been

Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report

Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon

Lamb Weston’s (LW) challenges may not end soon, a few points to note

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results

Comments

  1. Pingback: MBA tuition fees
  2. Pingback: academic advising
  3. Pingback: Fiverr Earn
  4. Pingback: Fiverr Earn
  5. Pingback: Fiverr Earn
  6. Pingback: Fiverr Earn
  7. Pingback: Fiverr Earn
  8. Pingback: fiverrearn.com
  9. Pingback: liv pure mediprime
  10. Pingback: red boost
  11. Pingback: fiverrearn.com
  12. Pingback: french bulldog
  13. Pingback: fiverrearn.com
  14. Pingback: dog kennel
  15. Pingback: frenchtons
  16. Pingback: isla mujeres
  17. Pingback: future university
  18. Pingback: future university
  19. Pingback: slot nexus
  20. Pingback: lean six sigma
  21. Pingback: FUE
  22. Pingback: FUE
  23. Pingback: FUE
  24. Pingback: Moving company
  25. Pingback: Reliable movers
  26. Pingback: Classic Books 500
  27. Pingback: FiverrEarn
  28. Pingback: FiverrEarn
  29. Pingback: Fiverr.Com
  30. Pingback: Fiverr.Com
  31. Pingback: FiverrEarn
  32. Pingback: Escorts Australia
  33. Pingback: pupuk cair
  34. Pingback: partners
  35. Pingback: Public Policy
  36. Pingback: FiverrEarn
  37. Pingback: live sex cams
  38. Pingback: FiverrEarn
  39. Pingback: FiverrEarn
  40. Pingback: FiverrEarn
  41. Pingback: FiverrEarn
  42. Pingback: FiverrEarn
  43. Pingback: FiverrEarn
  44. Pingback: FiverrEarn
  45. Pingback: FiverrEarn
  46. Pingback: filmebi qartulad
  47. Pingback: agriculture
  48. Pingback: christmas
  49. Pingback: Slot Gacor
  50. Pingback: FiverrEarn
  51. Pingback: FiverrEarn
  52. Pingback: sumatra tonic scam
  53. Pingback: cheap sex cams
  54. Pingback: fullersears.com
  55. Pingback: fullersears.com
  56. Pingback: dog probiotics
  57. Pingback: live sex cams
  58. Pingback: rare breed-trigger
  59. Pingback: 늑대닷컴
  60. Pingback: nangs sydney
  61. Pingback: allgame
  62. Pingback: 918kiss
  63. Pingback: หวย24
  64. Pingback: pg slot
  65. Pingback: Raahe Guide
  66. Pingback: 25-06 ammo
  67. Pingback: itsMasum.Com
  68. Pingback: itme.xyz
  69. Pingback: masumintl.com
  70. Pingback: ItMe.Xyz

Comments are closed.

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top